Tags : Asparlas

Servier’s Asparlas (calaspargase pegol-mknl) Receives FDA’s Approval for Acute Lymphoblastic

Shots: The approval is based on study assessing Asparlas (2500 U/m2, IV, q3w) in combination with multiagent chemotherapy in 124 patients with B-cell lineage ALL The study resulted in achievement and maintenance of nadir serum asparaginase activity above the level of 0.1 U/mL Asparlas (calaspargase pegol-mknl, IV) is an asparagine specific enzyme approved as a […]Read More